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Abstract
Objective: to prove the associated of serum Inhibin A levels 
in severe preeclampsia.
Methods : This was a cross-sectional study. Subjects 
consisted of 23 samples of normotensive pregnancy and 23 
of samples severe preeclampsia who meet the inclusion and 
exclusion criteria. This study was conducted and evaluated 
from September 2016 until December 2016 at the Department 
of Obstetrics and Gynecology Faculty of Medicine University 
of Sam Ratulangi Prof. Dr. R. D. Kandou Hospital Manado 
and satellite hospitals. Samples were analysed using ELISA 
method at Prodia laboratory. Data were analysed with SPSS 
version 20.0
Results: Mean serum Inhibin A levels in normotensive 
pregnancy is 477.22 pg/ml while mean in severe preeclampsia 
is 2712.39 pg/ml with p-value = 0.000.
Conclusions: Levels of serum Inhibin A in severe preeclampsia 
signifi cantly higher compared to normotensive pregnancy.
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Abstrak
Tujuan: untuk membuktikan hubungan kadar inhibin A 
serum pada preeclamsia berat.
Metode: penelitian ini merupakan studi analitik observasional 
dalam bentuk desain potong lintang. Dilakukan pemeriksaan 
kadar Inhibin A serum pada 46 sampel ibu hamil yang 
memenuhi kriteria inklusi dan eksklusi, terdiri atas 23 
kelompok preeclamsia berat dan 23 kelompok kehamilan 
normotesi. Penelitian dilaksanakan dan dievaluasi sejak 
bulan September 2016 sampai Desember 2016 di Bagian 
Obstetri dan Ginekologi Fakultas Kedokteran Universitas Sam 
Ratulangi / RSU Prof. dr. R. D. Kandou Manado dan rumah 
sakit jejaring. Analisis sampel dilakukan di Laboratorium 
Prodia Jakartamenggunakan metode ELISA. Data dianalisis 
denganSPSS versi 20.0.
Hasil: rerata kadar Inhibin A serum pada kelompok 
kehamilan normotesi yaitu 477,22 pg/ml sedangkan rerata 
pada kelompok preeklamsia berat yaitu  271,39 pg/ml 
dengan nilai p=0,000.
Kesimpulan: kadar Inhibin A serum pada preeklamsia 
berat lebih tinggi secara bermakna dibandingkan dengan 
kehamilan normotensi.
Kata kunci: inhibin A, normotensi, preeklamsia berat
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INTRODUCTION
Preeclampsia is an obstetric health problem 
where the aetiology is unclear and was fi rst 
diagnosed after 20 weeks of pregnancy. Some 
experts say that preeclampsia is a syndrome of 
several causes. Based on the recent classifi cation 
proposed by the National High Blood Pressure 
Education Program, the minimum diagnostic 
criteria for preeclampsia are hypertension, blood 
pressure ≥ 140/90 mmHg and proteinuria, urinary 
protein excretion ≥ 300 mg in 24 hours.1,2 
Various biochemical markers based on the 
pathophysiology of hypertension in pregnancy 
are proposed with the aim of predicting the 
progression of pregnancy towards preeclampsia. 
The latest study, Inhibin A group of glycoproteins 
produced by placenta syncytiotrophoblast can 
be used as a predictor of preeclampsia. Several 
studies have shown that levels of Inhibin A 
are signifi cantly increased in the circulation of 
pregnant women with preeclampsia without a clear 
mechanism. There is even research mentioning 
Inhibin A increases before preeclampsia occurs. 
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5
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Table 1. Subject Characteristics
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It is useful for clinical applications in identifying 
pregnant women at risk for preeclampsia.3-5 This 
study aims to prove the association of serum 
Inhibin A level in severe preeclampsia where this 
study is expected to provide input in an effort to 
reduce the incidence of severe preeclampsia.
METHOD
This was a cross-sectional study conducted 
from September 2016 until December 2016 at 
Department of Obstetrics and Gynecology Faculty 
of Medicine Universitas Sam Ratulangi Prof. 
Dr. R. D. Kandou Hospital Manado and satellite 
hospitals. The subject of this study consists of 
23 samples of normotensive pregnancy and 23 
samples of severe preeclampsia who meet the 
inclusion and exclusion criteria. The inclusion 
criteria include pregnant women more than 
20 weeks gestation, severe preeclampsia, 
superimposed preeclampsia and eclampsia, 
and willing to participate in research. Exclusion 
criteria include pregnant women with chronic 
hypertension, heart disease, liver, kidney, and 
diabetes mellitus. After anamnesis, physical 
examination and have informed consent, serum 
samples were taken from as many as 5 cc and 
put into a sterile sample container, centrifuged 
and stored at -70°C. Samples were analysed 
using ELISA method at Prodia laboratory. Data 
were analysed with SPSS version 20.0. This study 
has also been approved by the Integrated Health 
Research Unit (UPKT) Dr Prof. Dr. R. D. Kandou 
Manado. 
RESULT
A total of 23 samples of normotensive 
pregnancy and 23 samples of severe preeclampsia 
were recruited for this study.
Table 1 shows the subject of research in the 
normotensive group of pregnant women. Aged 
<35 years old group 18 people (78.26%) is the most, 
high school education group 19 people (82.61%) 
is found the most in normotensive pregnancy 
group, which is the most job as pregnancy 
group, which is the most job as a housemaid 22 
people (95.65%) in severe preeclampsia group, 
100% samples were taken at the age of 3rd 
trimester pregnancy in normotensive pregnancy, 
and multigravidity were 17 people (73.91%) in 
normotensive pregnancy group.
Inhibin A serum Level 
(pg/ml)
Mean
Median
Range
Std. Deviation
95% Confi dence Interval
477.22
343.00
1236
435.92
288.71 – 665.72
2712.39
1448.00
8378
2426.26
1663.20 – 3761.59
Normotensive 
Pregnancy
Severe 
Preeclampsia
Table 3.The Association of Serum Inhibin A Levels
Statistical Test
Mann – Whitney U 
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
46,000
322,000
-4,801
0.000
Value
Table 4. Statistic Test of Serum Inhibin A Levels
Normotensive Pregnancy
(Mean ± SD)
Severe Preeclampsia
(Mean ± SD) P-value
Clinical 
Manifestation 
Variable
Systolic BP
Diastolic BP
113.4 ± 10.632
72.17 ± 7.952
166.96 ± 8.757
107.83 ± 7.359
0.000
0.000
Table2. Variable Distribution of Age and Blood Pressure (BP) in Normotensive Pregnancy and Severe Preeclampsia
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In Table 3, serum Inhibin A levels in 
normotensive pregnancy group has mean 
477.22, median 343.00, range 1236, std. Deviation 
435.92, and 95% Confi dence Interval 288.71 - 
665.72. While serum Inhibin A levels in severe 
preeclampsia group has mean 2712,39, median 
1448.00, range 8378, std. Deviation 2426.26, and 
95% Confi dence Interval 1663.20 - 3761.59 
Table 4 shows statistic test of serum InhibinA 
levels. Mann-Whitney U value is 46,000, and 
Wilcoxon-W value is 322,000. If converted to a 
value of Z then the result is -4,801. So in Mann- 
Whitney test that p = 0,000 can be found which 
indicated there was a signifi cant difference of 
serum Inhibin A level between normotensive 
pregnancy group and severe preeclampsia group 
(p = 0,000). Finally, it can be concluded that 
levels of serum Inhibin A in severe preeclampsia 
signifi cantly higher compared to normotensive 
pregnancy.
DISCUSSION
Preeclampsia is a syndrome of various causes 
characterised by an increase in blood pressure with 
proteinuria in gestational age more than 20 weeks 
Concentrations of some protein markers in the 
maternal circulation increase in preeclampsia. The 
latest research, Inhibin A is a class of glycoproteins 
produced by placental syncytiotrophoblast and 
can be used as a predictor of preeclampsia. The 
aterm placental cells produce Inhibin A, which 
will increase as a response to infl ammatory 
cytokine in preeclampsia. In preeclampsia, there 
is a failure of extravillous trophoblast invasion 
(EVT) in the spiral artery myometrial segment 
and spiral artery remodelling is ineffective. 
Placental uterine circulation is maintained with 
high resistance conditions, resulting in decreased 
placental perfusion, placental insuffi ciency 
and inhibited blood fl ow to the fetus. Hypoxic 
placental conditions increase the production 
and synthesis of reactive oxygen species (ROS). 
ROS is involved in the stimulation of α and 
βA Inhibin gene expression by the placenta, 
resulting in elevated serum Inhibin A levels. In 
addition to increased ROS, placental hypoxia 
leads to increased production of cytokines, such 
as IL-1β and TNF-α. IL-1β increases production 
and synthesis of Inhibin A, while TNF- α inhibits 
synthesis of InhibinA.6-9 
The subject of this study consists of 23 samples 
normotensive pregnancy and 23 samples severe 
preeclampsia, using age, education, marriage, 
and maternal parity as subject characteristics. 
Based on the subject characteristics, the 
highest number of maternal age in normotensive 
pregnancy group and severe preeclampsia group 
was <35 years, wherein the group of normotensive 
pregnancy are 18 people (78.26%), and severe 
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preeclampsia group are 16 (69.57%). For high 
school education group, the highest number is 
in normotensive pregnancy which has 19 people 
(82.61%), and severe preeclampsia group which 
has 17 people (73.91%). Housemaid job is the 
highest in normotensive pregnancy group, which 
has 19 people (82.61%) and severe preeclampsia 
group which has 22 people (95.65). 100% of the 
samples were taken at the age of 3rd trimester of 
pregnancy in normotensive pregnancy. The last 
subject characteristics were parity, wherein the 
group of normotensive pregnancy, the highest 
number was found in multigravida which has 
17 people (73.91%) whereas in the group of 
preeclampsia the highest was primigravida which 
has 13 people (56.52%). This is consistent with 
the theory that the frequency of preeclampsia is 
higher in primigravida than multigravida because 
of the insuffi cient formation of antibody inhibitors 
that increases the risk of preeclampsia.10,11 
Inhibin A serum test in this study showed 
signifi cantly different results in the group of 
normotensive pregnancy and severe preeclampsia 
group. The mean value of Inhibin A serum level 
in the severe preeclampsia group was higher 
than the normal group, which is 477.22 pg/
ml in the normotensive pregnancy group and 
2712.39 pg/ml in the severe preeclampsia group. 
From the statistic test of serum Inhibin A level, 
p = 0.000 was obtained, meaning that there 
was a signifi cant difference of serum Inhibin 
A level in normotensive pregnancy group and 
severe preeclampsia group. This proves there is 
a correlation of serum Inhibin A level with severe 
preeclampsia events.10 
The results of this study support the researches 
that have been done by previous researchers. 
Initial studies about increased Inbihin A in 
severe preeclampsia were fi rst performed by 
Muttukhrisna (1997) with a signifi cant increase 
in Inhibin A serum on preeclampsia. The study 
was conducted on 20 women with normal 
pregnancies and 20 women with preeclampsia. 
He concluded that in normal pregnancy, Inhibin 
A levels will increase in the third trimester, and 
show a tenfold increase level in pregnant women 
with severe preeclampsia. Whereas in the second 
trimester, Inhibin A levels showed an increase in 
both maternal blood serum and in amnionic fl uid 
of pregnant women which progressed toward 
preeclampsia and that elevated level is related to 
the severity of preeclampsia symptoms. Increased 
Inhibin A level in preeclampsia is due to the 
production of placental tissue and illustrate that 
preeclampsia occurs in abnormal placentas and 
as a result of failed trophoblast function.4,5 
Another study on Inhibin A serum level in 
severe preeclampsia was performed by Zeeman 
et al. (2005). The study was conducted on 232 
pregnant women who observed for two months. 
Inhibin A serum level showed an increase in mild 
preeclampsia and severe preeclampsia, whereas 
in chronic hypertension and hypertension in 
pregnancy have an Inhibin A level almost equal 
to normal pregnancy.12,13
El-Gharib and Morad (2010) said that 
Inhibin A serum level in maternal could predict 
preeclampsia. The study was conducted on 326 
primigravida who performed prenatal care at 
Tanta University Hospital, Egypt. Pregnancy is 
confi rmed by ultrasound, and informed consent 
is required on all expectant mothers. Women 
with multifetal pregnancies, infections, diabetes 
mellitus, and a history of hypertension or kidney 
disease were excluded from the study. And the 
subjects of the study were divided into 2 groups. 
The results showed that Inhibin A serum level had 
a very high increase in severe preeclampsia.14
CONCLUSION
Levels of serum Inhibin A in severe 
preeclampsia signifi cantly higher compared to 
normotensive pregnancy. So it can be concluded 
that serum Inhibin A level is associated with 
severe preeclampsia.
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